The cognitive cost of anticholinergic burden: Decreased response to cognitive training in schizophrenia

American Journal of Psychiatry

Volumn 166, Issue 9, 2009, Pages 1055-1062

  Vinogradov, Sophia ^a   Fisher, Melissa ^a   Warm, Heather ^a   Holland, Christine ^a   Kirshner, Margaret A ^a   Pollock, Bruce G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICHOLINERGIC EFFECT; ARTICLE; CHOLINESTERASE BLOOD LEVEL; COGNITION; COMPUTER SYSTEM; CONTROLLED STUDY; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; LEARNING; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RADIORECEPTOR ASSAY; RAT; SCHIZOPHRENIA; TRAINING; WORKING MEMORY;

ADULT; ANIMALS; ATROPINE; CHOLINERGIC ANTAGONISTS; COGNITION DISORDERS; COGNITIVE THERAPY; FEMALE; GAMES, EXPERIMENTAL; HUMANS; MALE; MIDDLE AGED; NEURONAL PLASTICITY; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 69949103030     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2009.09010017     Document Type: Article

References (35)

1. Perlick D, Stastny P, Katz I, Mayer M, Mattis S: Memory deficits and anticholinergic levels in chronic schizophrenia. Am J Psychiatry 1986; 143:230-232 (Pubitemid 16114371)
2. Tune LE, Strauss ME, Lew MF, Breitlinger E, Coyle JT: Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients. Am J Psychiatry 1982; 139:1460-1462
3. Chew ML, Mulsant BH, Pollock BG, Lehman ME, Greenspan A, Kirshner MA, Bies RR, Kapur S, Gharabawi G: A model of anticholinergic activity of atypical antipsychotic medications. Schizophr Res 2006; 88:63-72 (Pubitemid 44693242)
4. Terry AV Jr, Gearhart DA, Mahadik SP, Warsi S, Waller JL: Chronic treatment with first or second generation antipsychotics in rodents: effects on high affinity nicotinic and muscarinic acetylcholine receptors in the brain. Neuroscience 2006; 140:1277-1287 (Pubitemid 43928280)
5. Tracy JI, Monaco C, Giovannetti T, Abraham G, Josiassen RC: Anticholinergicity and cognitive processing in chronic schizophrenia. Biol Psychol 2001; 56:1-22 (Pubitemid 32178099)
6. Nebes RD, Pollock BG, Houck PR, Butters MA, Mulsant BH, Zmuda MD, Reynolds CF 3rd: Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. J Psychiatr Res 2003; 37:99-108
7. Mulsant BH, Pollock BG, Kirshner M, Shen C, Dodge H, Ganguli M: Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 2003; 60:198-203 (Pubitemid 36173127)
8. Minzenberg MJ, Poole JH, Benton C, Vinogradov S: Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. Am J Psychiatry 2004; 161:116-124 (Pubitemid 38419316)
9. McGurk SR, Green MF, Wirshing WC, Wirshing DA, Marder SR, Mintz J, Kern R: Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia. Schizophr Res 2004; 68:225-233 (Pubitemid 38526145)
10. Spohn HE, Strauss ME: Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J Abnorm Psychol 1989; 98:367-380
11. Strauss ME, Reynolds KS, Jayaram G, Tune LE: Effects of anticholinergic medication on memory in schizophrenia. Schizophr Res 1990; 3:127-129 (Pubitemid 20112987)
12. Chudasama Y, Dalley JW, Nathwani F, Bouger P, Robbins TW: Cholinergic modulation of visual attention and working memory: dissociable effects of basal forebrain 192-IgG-saporin lesions and intraprefrontal infusions of scopolamine. Learn Mem 2004; 11:78-86 (Pubitemid 38167061)
13. McGaughy J, Dalley JW, Morrison CH, Everitt BJ, Robbins TW: Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusions of 192 IgG-saporin on attentional performance in a five-choice serial reaction time task. J Neurosci 2002; 22:1905-1913 (Pubitemid 35386309)
14. Risbrough V, Bontempi B, Menzaghi F: Selective immunolesioning of the basal forebrain cholinergic neurons in rats: effect on attention using the 5-choice serial reaction time task. Psychopharmacology (Berl) 2002; 164:71-81 (Pubitemid 35203844)
15. Leanza G, Muir J, Nilsson OG, Wiley RG, Dunnett SB, Bjorklund A: Selective immunolesioning of the basal forebrain cholinergic system disrupts short-term memory in rats. Eur J Neurosci 1996; 8:1535-1544 (Pubitemid 26239833)
16. Ellis JR, Ellis KA, Bartholomeusz CF, Harrison BJ, Wesnes KA, Erskine FF, Vitetta L, Nathan PJ: Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. Int J Neuropsychopharmacol 2006; 9:175-189 (Pubitemid 43255831)
17. Sarter M, Hasselmo ME, Bruno JP, Givens B: Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brain Res Brain Res Rev 2005; 48:98-111
18. Kilgard MP, Merzenich MM: Cortical map reorganization enabled by nucleus basalis activity. Science 1998; 279:1714-1718
19. Kuo MF, Grosch J, Fregni F, Paulus W, Nitsche MA: Focusing effect of acetylcholine on neuroplasticity in the human motor cortex. J Neurosci 2007; 27:14442-14447
20. Froemke RC, Merzenich MM, Schreiner CE: A synaptic memory trace for cortical receptive field plasticity. Nature 2007; 450:425-429
21. Green A, Ellis KA, Ellis J, Bartholomeusz CF, Ilic S, Croft RJ, Phan KL, Nathan PJ: Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans. Pharmacol Biochem Behav 2005; 81:575-584 (Pubitemid 40966805)
22. Fisher M, Holland C, Merzenich MM, Vinogradov S: Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am J Psychiatry 2009; 166:805-811
23. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-276 (Pubitemid 18039085)
24. Nuechterlein KH, Green MF: MATRICS Consensus Cognitive Battery Manual. Los Angeles, Calif, MATRICS Assessment, Inc, 2006
25. Nebes RD, Pollock BG, Mulsant BH, Kirshner MA, Halligan E, Zmuda M, Reynolds CF 3rd: Low-level serum anticholinergicity as a source of baseline cognitive heterogeneity in geriatric depressed patients. Psychopharmacol Bull 1997; 33:715-720 (Pubitemid 28128127)
26. Tune L, Coyle JT: Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch Gen Psychiatry 1980; 37:293-297 (Pubitemid 10102554)
27. Pollock BG, Mulsant BH, Nebes R, Kirshner MA, Begley AE, Mazumdar S, Reynolds CF III: Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline. Am J Psychiatry 1998; 155:1110-1112 (Pubitemid 28357741)
28. Chew ML, Mulsant BH, Pollock BG: Serum anticholinergic activity and cognition in patients with moderate-to-severe dementia. Am J Geriatr Psychiatry 2005; 13:535-538
29. Nebes RD, Pollock BG, Meltzer CC, Saxton JA, Houck PR, Halligan EM, DeKosky ST: Serum anticholinergic activity, white matter hyperintensities, and cognitive performance. Neurology 2005; 65:1487-1489 (Pubitemid 41552789)
30. Fiszdon JM, Choi J, Goulet J, Bell MD: Temporal relationship between change in cognition and change in functioning in schizophrenia. Schizophr Res 2008; 105:105-113
31. Reeder C, Smedley N, Butt K, Bogner D, Wykes T: Cognitive predictors of social functioning improvements following cognitive remediation for schizophrenia. Schizophr Bull 2006; 32(suppl 1):S123-S131
32. McGurk SR, Mueser KT, Harvey PD, LaPuglia R, Marder J: Cognitive and symptom predictors of work outcomes for clients with schizophrenia in supported employment. Psychiatr Serv 2003; 54:1129-1135 (Pubitemid 36951514)
33. McGurk SR, Mueser KT: Cognitive functioning, symptoms, and work in supported employment: a review and heuristic model. Schizophr Res 2004; 70:147-173
34. Brekke JS, Hoe M, Long J, Green MF: How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Schizophr Bull 2007; 33:1247-1256 (Pubitemid 47347914)
35. Harvey PD, Moriarty PJ, Serper MR, Schnur E, Lieber D: Practice-related improvement in information processing with novel antipsychotic treatment. Schizophr Res 2000; 46:139-148